Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector




















Sort by: Date|Relevance

A Revolution in Healthcare. A Transformative Investment Opportunity.

(Click image to play video) While the global COVID-19 pandemic has wreaked havoc on health and humanity over the past 12-month-plus, it has also invited a host of creative and innovative solutions to meet the needs of people who require a medical attention witho...

Covid 19: Will pain-free, at-home screening tests be our salvation?

The world’s best defence against the spread of COVID-19 in 2021 will not be a vaccine, medical experts now say. Instead, it will be the widespread adoption of cheap, non-invasive diagnostic detection devices for coronaviruses – ones that look and function...

Best Microcap Stocks

Some market components, such as small capitalization companies, require a little persuasion. Whether it’s their potential to produce incredible gains, or the chance to get in early on a growing industry, small-cap stocks present enticing opportunities. While ...

Chimerix Shares Rise 50% as FDA Gives 'Go Ahead' for Phase 2/3 ALI Study in COVID-19 Patients

Shares of Chimerix Inc. traded higher after the company reported it has received U.S. FDA clearance to initiate a Phase 2/3 Study of dociparstat sodium in acute lung injury for patients afflicted with severe COVID-19. Biopharmaceutical company Chimerix Inc....

Emerging Technologies to Drive Silver Demand

The price of silver soared in May, jumping more than 19 percent on safe haven demand as well as increased expectations of a swift economic recovery, given its many industrial applications. Not only was this silver’s best month since 2011, but it also mar...

Dec 13th 2019, Crypto Chartbook – Building positions, arriving at target loaded

Building positions, arriving at target loaded December markets are tricky. With the closing of the year come rollovers in futures markets, tax considerations, hedge fund portfolio allocations due to accountability and much more. Markets are a reflection of human behavior a...

Saturn Oil & Gas, TORC Oil & Gas, Whitecap Resources - it's time for harmless oil!

In recent years, there has been a growing trend in modern society that food must originate from the region and a declaration as 'organic' is now considered mandatory. Coffee beans from distant countries should definitely carry the label 'Fairtrade' and blood diamonds are right...

BioNTech, Gilead, Memphasys - in the spotlight of investors overnight

There are topics and products that are the focus of general interest overnight. Often these are needs or problems that require a time-critical solution. The current situation surrounding the spread of the Corona Virus COVID-19 has brought numerous companies into the focus of i...

Memphasys, Moderna, Paion - Investments in solutions with potential

Biotech companies around the world employ scientists and physicians to study the causes of diseases. The research and development of medical products and solutions usually involves a large number of tests and takes a correspondingly long time. The longer and more extensive thi...

BioNTech, Evotec, EXMceuticals - which stocks have the potential to double?

Experienced investors assume that the DAX, Germany's leading index, will still reach new highs in 2020. One of the best-known supporters of this scenario is the asset manager Dr. Jens Ehrhardt. Rising markets are supported by the measures taken by central banks and politicians...
1 2 3 4 5 6 7 8 9 10 ...